Pediatric Infectious Disease Part Ii An Issue Of Infectious Disease Clinics Of North America
Download Pediatric Infectious Disease Part Ii An Issue Of Infectious Disease Clinics Of North America full books in PDF, epub, and Kindle. Read online free Pediatric Infectious Disease Part Ii An Issue Of Infectious Disease Clinics Of North America ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Mary Anne Jackson |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 201 |
| Release | : 2016-01-19 |
| Genre | : Medical |
| ISBN | : 0323402534 |
This issue of Infectious Disease Clinics of North America, Guest Edited by Mary Anne Jackson, MD and Angela Myers, MD, is Part II of a 2-part issue devoted to Pediatric Infectious Diseases. Drs. Jackson and Myers have assembled a group of expert authors to review the following topics: Measles 50 Years After Initiation of MMR Vaccine; Pertussis in the Era of New Strains; Promoting Vaccine Confidence; The Changing Epidemiology of Meningococcal Infection; Prevention of Influenza in Children; Rabies - Rare Human Infection, Common Questions; The Expanded Impact of Human Papillomavirus Vaccine; The Challenge of Global Poliomyelitis Eradication; The Eradication of Pediatric Rotavirus Infection; Approach to Immunization for the Traveling Child; and Status of Pneumococcal Infection in the US in the conjugate vaccine era.
| Author | : Mary Anne Jackson |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 225 |
| Release | : 2015-09-07 |
| Genre | : Medical |
| ISBN | : 0323395686 |
This issue of Infectious Disease Clinics of North America, Guest Edited by Mary Anne Jackson, MD and Angela Myers, MD, is Part I of a 2-part issue devoted to Pediatric Infectious Diseases. Drs. Jackson and Myers have assembled a group of expert authors to review the following topics: Diagnosis and Management of Kawasaki Disease; Neonatal HSV Infection; Use of Newer Diagnostics for Pediatric Tuberculosis; Recognition and Prompt Treatment for Tick Borne Infections; Prevention of Recurrent Staphylococcal Skin Infections; Evaluation and Management of the Febrile Young Infant; New Horizons for Pediatric Antimicrobial Stewardship; Pitfalls in Diagnosis of Pediatric Clostridium Difficile Diarrhea; The Changing Epidemiology of Pediatric Endocarditis; Neonatal Parechovirus Infection; Osteoarticular infections in Children; and Pediatric CMV Disease.
| Author | : Michael S. Saag |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 145 |
| Release | : 2014-11-27 |
| Genre | : Medical |
| ISBN | : 0323326552 |
This second part of a 2-part issue of Infectious Disease Clinics, edited by Michael S. Saag, MD and Henry Masur, MD, is devoted to HIV/AIDS. This issue will address the prevention of HIV/AIDS with topics such as: Mother to Child Transmission; Treatment as Prevention; Barrier and Microbicides; Prevention of HIV/AIDS: Pre-exposure Prophylaxis; Post-Exposure Prophylaxis; HIV Vaccine, and a final article addressing the cure of HIV/AIDS.
| Author | : Mark H. Wilcox |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 201 |
| Release | : 2015-04-07 |
| Genre | : Medical |
| ISBN | : 032335680X |
This issue of Infectious Disease Clinics of North America, guest edited by Dr. Mark H. Wilcox, is devoted to Clostridium Difficile Infection. Articles in this issue include: Potential sources of C. difficile for human infection; Colonisation versus carriage of C. difficile; Diagnostic pitfalls in C. difficile infection; The epidemiology of C. difficile infection in and outside of healthcare institutions; What makes epidemic C. difficile strains epidemic?: Fact versus fiction; Environmental interventions to control C. difficile infection; The contribution of strains and hosts to outcomes in C. difficile infection; Treatment of C. difficile infection; Faecal microbiota transplantation for the management of C. difficile infection; The morbidity, mortality, and costs associated with C. difficile infection; The potential of probiotics to prevent C. difficile infection; The prospect for vaccines to prevent C. difficile infection; and Predictive value of models of C. difficile infection.
| Author | : Luis Ostrosky-Zeichner |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 329 |
| Release | : 2016-03-12 |
| Genre | : Medical |
| ISBN | : 0323416500 |
There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidemiology of invasive mycoses continues to emerge. The diagnosis of these infections remains difficult, and treatment outcomes in highly immunosuppressed patients remain poor. Thus, this issue is devoted to state-of-the-art updates on fungal infections by internationally recognized authorities in this field. Some topics covered are Antifungal agents; State-of-the-art culture, identification, and resistance testing of fungal pathogens; Non-culture diagnostics in fungal disease; Contemporary strategies in the prevention and management of fungal infections; Invasive candidiasis; Invasive aspergillosis; Mucormycoses; and Cryptococcosis to name a few.
| Author | : Jason G. Newland |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 249 |
| Release | : 2022-02-24 |
| Genre | : Medical |
| ISBN | : 0323835430 |
In this issue, guest editors bring their considerable expertise to this important topic.Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
| Author | : Robert A. Bonomo |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 273 |
| Release | : 2016-06-11 |
| Genre | : Medical |
| ISBN | : 0323446191 |
For many years, physicians and the public assumed that the discovery of new antimicrobial agents would outpace the ability of bacteria to mutate and develop drug resistance. Yet the development of new antibiotics has not kept up with bacterial evolution, especially since the late 1990’s. At that time a multitude of pharmaceutical companies abandoned antibiotic research because of strong economic disincentives. For example, it is challenging for these companies to recuperate the investment (typically in the hundreds of millions of dollars) made in developing a new antibiotic, which is typically prescribed for a few days, compared to drugs that treat chronic conditions like heart disease or mental illness. This situation has led the U.S. federal government to take a more active lead in addressing antibiotic resistance. Recently, the White House announced an action plan that includes improving surveillance, developing better diagnostic tools, accelerating drug development, and improving global coordination of antibiotic resistance issues. Equally important is the $1.2 billion dollars that has been pledged to fund these efforts. While we await the implementation of new policies, this issue of Infectious Disease Clinics of North America brings together leading authorities in the field of antibiotic resistance who discuss current issues including antibiotic stewardship, the changing role of the microbiology laboratory in determining antibiotic resistance in gram-negative pathogens, the continuing spread of metallo-ß-lactamases, ESBLs and KPCs, antibiotic options for treating resistant gram-negative infections such as colistin and tigecycline, resistance mechanisms and new treatment options for Mycobacterium tuberculosis, emerging resistance mechanisms in aminoglycosides, issues with antibiotic resistance in immunocompromised patients, new ß-lactamase inhibitors in the clinic, and resistance in VRE and Staphylococcus aureus. Additionally, combination therapy for resistant gram-negative infections has been advocated by some authorities and the advantages and disadvantages of this strategy will be reviewed.
| Author | : James P. Nataro |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 249 |
| Release | : 2017-08-01 |
| Genre | : Medical |
| ISBN | : 0323532527 |
Children in developing countries continue to be susceptible to infectious and non-infectious disorders that lead to growth retardation, cognitive impairment and high infant and childhood mortality. Clinical, epidemiologic and pathogenetic studies are providing opportunities to intervene against these disorders as never before. In this issue, international experts in child health offer their perspectives on the problems of greatest import to the health of children growing up in impoverished environments. Opportunities for research and intervention are particularly emphasized. Articles are specifically devoted to the following topics: Child Health and Survival in a Changing World; Childhood Nutrition and Growth; Children with Disabilities in the Developing Nations; The Burden of Enteropathy and Subclinical Infections; Malaria in Children; The Unholy Trinity: Nematode Infections in Developing Countries; The Burden and Etiology of Diarrheal Illness in Developing Countries; Intestinal Protozoal Infections; Pneumonia and Respiratory Infections; Primary Bacteremia and Meningitis in Developing Countries; Neonatal and Perinatal Infections; HIV in Developing Countries; and Tuberculosis in Children.
| Author | : Robert Kliegman |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 313 |
| Release | : 2016-12-01 |
| Genre | : Medical |
| ISBN | : 0323496725 |
Dr. Kliegman and Dr. Bordini have written a primer on Undiagnosed and Rare Diseases in Children. Leading experts have presented the current knowledge in the following areas: How Doctor’s Think: Common Diagnostic Errors in Clinical Judgment; Team-Based Approach to Undiagnosed and Rare Diseases; Ending a Diagnostic Odyssey: Family Education Counselling and Their Response to Eventual Diagnosis; Eczema and Urticaria as Manifestations of Undiagnosed and Rare Diseases; Usual and Unusual Manifestations of Familial Hemophagocytic and Langerhans Cell Histiocytosis Syndromes; When Autistic Behavior Suggests a Disease Other than Classic Autism; Non-classic Inflammatory Bowel Disease in Young Infants; IPEX and Other Disorders; Usual and Unusual Presentation of Mitochondrial Disorders; When to Suspect Auto-inflammatory/Recurrent Fever Syndromes; Primary and Secondary Causes of Autonomic Dysfunction; Usual and Unusual Manifestations of Systemic and CNS Vasculitis; Fever of Unknown Origin; Differentiating Familial Neuropathies from Guillain-Barre Syndrome; and Munchausen by Proxy: A Factitious Undiagnosed Disease. Readers will come away with cutting-edge information to use immediately in their clinical management of patients.
| Author | : Keith S. Kaye |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 305 |
| Release | : 2016-08-16 |
| Genre | : Medical |
| ISBN | : 0323462790 |
Dr. Kaye and Dr. Dhor have assembled top experts to write about facility planning and management in Part I of their two issues devoted to Infection Prevention and Control in Healthcare. Articles in this issue are devoted to: Building a Successful Infection Control Program: Key Components, Processes and Economics; Hand Hygiene Sterilization; High Level Disinfection and Environmental Cleaning; Environement of Care; Infection Control in Alternative Healthcare Settings (Long Term Care and Ambulatory); Antibiotic Stewardship; Outbreak InvestigationsWater Safety in Healthcare/Legionella in the Healthcare Setting; Construction and Renovation; Bloodborne and Body Fluid Exposures - prevention and management of Occupational Health Issues; and Informatics and Statistics in Infection Control. Part II is devoted to clinical management of infections.
